These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 12511858)

  • 1. Plasma membrane monoamine transporters: structure, regulation and function.
    Torres GE; Gainetdinov RR; Caron MG
    Nat Rev Neurosci; 2003 Jan; 4(1):13-25. PubMed ID: 12511858
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychostimulants and monoamine transporters: upsetting the balance.
    Elliott JM; Beveridge TJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):94-100. PubMed ID: 15661632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport mechanisms in acetylcholine and monoamine storage.
    Parsons SM
    FASEB J; 2000 Dec; 14(15):2423-34. PubMed ID: 11099460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
    Numis AL; Unger EL; Sheridan DL; Chisnell AC; Andrews AM
    Mol Pharmacol; 2004 Sep; 66(3):718-27. PubMed ID: 15322265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to identify monoamine transporter interacting proteins.
    Torres GE; Caron MG
    J Neurosci Methods; 2005 Apr; 143(1):63-8. PubMed ID: 15763137
    [No Abstract]   [Full Text] [Related]  

  • 6. Repeated swim stress leads to down-regulation of vesicular monoamine transporter 2 in rat brain nucleus accumbens and striatum.
    Zucker M; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):199-201. PubMed ID: 15695065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acidic motif retains vesicular monoamine transporter 2 on large dense core vesicles.
    Waites CL; Mehta A; Tan PK; Thomas G; Edwards RH; Krantz DE
    J Cell Biol; 2001 Mar; 152(6):1159-68. PubMed ID: 11257117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical neuroanatomy of the vesicular amine transporters.
    Weihe E; Eiden LE
    FASEB J; 2000 Dec; 14(15):2435-49. PubMed ID: 11099461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studying monoamine transporters: beyond hypermonoaminaemia.
    Reith ME
    J Neurosci Methods; 2005 Apr; 143(1):1-2. PubMed ID: 15763131
    [No Abstract]   [Full Text] [Related]  

  • 10. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.
    Bottalico B; Larsson I; Brodszki J; Hernandez-Andrade E; Casslén B; Marsál K; Hansson SR
    Placenta; 2004 Jul; 25(6):518-29. PubMed ID: 15135235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and biochemical studies of rat vesicular monoamine transporter.
    Schuldiner S; Steiner-Mordoch S; Yelin R
    Adv Pharmacol; 1998; 42():223-7. PubMed ID: 9327884
    [No Abstract]   [Full Text] [Related]  

  • 12. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors.
    Duerr JS; Frisby DL; Gaskin J; Duke A; Asermely K; Huddleston D; Eiden LE; Rand JB
    J Neurosci; 1999 Jan; 19(1):72-84. PubMed ID: 9870940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of vesicular GABA transporter, but not vesicular glutamate, acetylcholine and monoamine transporters in rat brain following focal ischemia.
    Vemuganti R
    Neurochem Int; 2005 Jul; 47(1-2):136-42. PubMed ID: 15936116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a series of 3-amino-2-phenylpropene derivatives as novel bovine chromaffin vesicular monoamine transporter inhibitors.
    Perera RP; Wimalasena DS; Wimalasena K
    J Med Chem; 2003 Jun; 46(13):2599-605. PubMed ID: 12801224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters.
    Vaughan RA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):1-7. PubMed ID: 15064332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vesicular neurotransmitter transporters: current perspectives and future prospects.
    Eiden LE
    FASEB J; 2000 Dec; 14(15):2396-400. PubMed ID: 11099457
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased platelet vesicular monoamine transporter density in habitual smokers.
    Schwartz K; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):235-8. PubMed ID: 15695071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobelane analogues as novel ligands for the vesicular monoamine transporter-2.
    Zheng G; Dwoskin LP; Deaciuc AG; Zhu J; Jones MD; Crooks PA
    Bioorg Med Chem; 2005 Jun; 13(12):3899-909. PubMed ID: 15911306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of serotonin transporter in blood lymphocytes of rats. Modulation by in vivo administration of mitogens.
    Cedeño N; Urbina M; Obregón F; Lima L
    J Neuroimmunol; 2005 Feb; 159(1-2):31-40. PubMed ID: 15652400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand recognition by the vesicular monoamine transporters.
    Finn JP; Merickel A; Peter D; Edwards RH
    Adv Pharmacol; 1998; 42():232-6. PubMed ID: 9327886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.